Clinical investigation to support new uses generally requires an Investigational New Drug (IND) application with appropriate chemistry, manufacturing, and controls, nonclinical safety, and human data
3.2 Therapeutic potential in obesity Although the incretin effects of GIPR undoubtedly play a crucial role in preventing postprandial glucose excursion, there is still intensive debate on whether the GIPR should be activated or inhibited for the treatment of obesity
This creates a state of cellular exhaustion that cannot be resolved by simply resting or sleeping
Bookshelf ID: NBK557767 Diana P (2007): Tetrabenazine in the treatment of Huntingtons disease
optimized to yield up to 10mg of soluble GST tagged protein
Taking an additional dose without guidance can be risky, and skipping doses without guidance can also disrupt your plan